Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its produ…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-05
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Material change report - English.pdf
News 2026-05-05
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
News release - English.pdf
Results 2026-04-01
Interim MD&A - English.pdf
Results 2026-04-01
Interim financial statements/report – English.pdf
News 2026-03-31
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
Material change report - English.pdf
News 2026-03-31
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
News release - English.pdf
News 2026-02-11
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA™ Stroke Platform; Targets 2026 U.S. FDA Trial
Material change report - English.pdf
News 2026-02-10
Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial
News release - English.pdf
News 2026-01-20
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Material change report - English.pdf
News 2026-01-20
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
News release - English.pdf
Results 2025-12-22 Financials
Interim MD&A - English.pdf
Results 2025-12-22 Financials
Interim financial statements/report – English.pdf
News 2025-12-19
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Material change report - English.pdf
News 2025-12-18
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
News release - English.pdf
Results 2025-12-01 Financials
Annual MD&A - English.pdf
Results 2025-12-01 Financials
Audited annual financial statements – English.pdf
News 2025-11-07
Report of exempt distribution (45-106F1).pdf
News 2025-10-21
Other.pdf
News 2025-10-20
Letter from successor auditor.pdf
News 2025-10-20
Notice.pdf
News 2025-10-20
Letter from former auditor.pdf
News 2025-10-11
Material change report - English.pdf
News 2025-10-10
News release - English.pdf
News 2025-09-24
Material change report - English.pdf
News 2025-09-24
News release - English.pdf
News 2025-08-29
Material change report - English.pdf
News 2025-08-28
News release - English.pdf
News 2025-07-11
Report of exempt distribution (45-106F1).pdf
News 2025-07-03
Material change report - English.pdf
News 2025-07-03
News release - English.pdf
Results 2025-06-25 Financials
Interim MD&A - English.pdf
Results 2025-06-25 Financials
Interim financial statements/report – English.pdf
News 2025-06-11
Material change report - English.pdf
News 2025-06-11
News release - English.pdf
News 2025-06-05
Material change report - English.pdf
News 2025-06-05
News release - English.pdf